Close

Sign in
Sign up

Menu

Data Search
Content
Startup Concierge
Newsletters
Get intel

Home
News
Vico in a $60M Series B deal led by Ackermans & van Haaren (AvH), w/ Droia Ventures, EQT, Kurma Partners, Polaris Partners, Pureos Bioventures and Eurazeo.

Vico in a $60M Series B deal led by Ackermans & van Haaren (AvH), w/ Droia Ventures, EQT, Kurma Partners, Polaris Partners, Pureos Bioventures and Eurazeo.

Biotech Health services Manufacturing

Sweden

Switzerland

France

Netherlands

United States

Belgium

Luxembourg

Investments

30 December 2023

Share:

Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!

Vico Therapeutics (company)

Netherlands

Biotech Health services Manufacturing

Total investments received (USD): 103.42M

Round value (USD): 60M

Round investors: EQT Partners Eurazeo Polaris Partners Pureos Bioventures Kurma Life Science Partners Droia Ventures Ackermans & van Haaren

Company: Vico Therapeutics

Industry: Biotech Health services Manufacturing

Related deals

Vitestro raised a $70 million Series B round with Labcorp Venture, Mayo Clinic, Sutter Health, InterVest, MGFO, PGGM, Puma Venture Capital and ROM Utrecht

Health services Manufacturing Software Services

United Kingdom

Netherlands

United States

Belgium

South Korea

Investments 01 March 2026

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2026. Made with in Stockholm

Top